Executive Summary
MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses.
Snowflake
Fundamentals
Undervalued established dividend payer.
Similar Companies
Share Price & News
How has MetLife's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
5.5%
MWZ
3.1%
DE Insurance
4.1%
DE Market
1 Year Return
10.7%
MWZ
21.8%
DE Insurance
2.4%
DE Market
Return vs Industry: MWZ underperformed the German Insurance industry which returned 21.8% over the past year.
Return vs Market: MWZ exceeded the German Market which returned 2.4% over the past year.
Shareholder returns
| MWZ | Industry | Market | |
|---|---|---|---|
| 7 Day | 5.5% | 3.1% | 4.1% |
| 30 Day | -2.7% | 3.7% | 1.7% |
| 90 Day | -4.3% | 2.9% | 3.7% |
| 1 Year | 14.9%10.7% | 27.2%21.8% | 5.6%2.4% |
| 3 Year | 8.8%-1.8% | 70.3%49.7% | 19.2%8.9% |
| 5 Year | 24.4%5.5% | 120.2%76.4% | 43.2%23.7% |
Price Volatility Vs. Market
How volatile is MetLife's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Valuation
Is MetLife undervalued compared to its fair value and its price relative to the market?
43.9%
Undervalued compared to fair value
Share Price vs. Fair Value
Undervalued: MWZ (€42) is trading below our estimate of fair value (€74.83)
Significantly Undervalued: MWZ is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: MWZ is good value based on its PE Ratio (7.6x) compared to the Insurance industry average (13.5x).
PE vs Market: MWZ is good value based on its PE Ratio (7.6x) compared to the German market (19.5x).
Price to Earnings Growth Ratio
Low PEG Ratio: MWZ's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: MWZ is good value based on its PB Ratio (0.7x) compared to the DE Insurance industry average (1.1x).
Next Steps
Future Growth
How is MetLife forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
-3.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MWZ's earnings are forecast to decline over the next 3 years (-3.7% per year).
Earnings vs Market: MWZ's earnings are forecast to decline over the next 3 years (-3.7% per year).
High Growth Earnings: MWZ's earnings are forecast to decline over the next 3 years.
Revenue vs Market: MWZ's revenue (2.5% per year) is forecast to grow slower than the German market (5% per year).
High Growth Revenue: MWZ's revenue (2.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
High Future ROE: MWZ's Return on Equity is forecast to be low in 3 years time (11%).
Next Steps
Past Performance
How has MetLife performed over the past 5 years?
-4.2%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: MWZ's earnings have declined by -4.2% per year over the past 5 years.
Accelerating Growth: MWZ's earnings growth over the past year (13.1%) exceeds its 5-year average (-4.2% per year).
Earnings vs Industry: MWZ earnings growth over the past year (13.1%) underperformed the Insurance industry 15.2%.
Return on Equity
High ROE: MWZ's Return on Equity (9.5%) is considered low.
Return on Assets
ROA vs Industry: MWZ has a higher Return on Assets than the Insurance industry average last year.
Return on Capital Employed
ROCE Improving: MWZ has significantly improved its Return on Capital Employed over the past 3 years.
Next Steps
Financial Health
How is MetLife's financial position? (This company is analysed differently as a bank or financial institution)
Financial Position Analysis
Debt to Equity History and Analysis
Balance Sheet
Inventory Level: MWZ has a low level of unsold assets or inventory.
Debt Coverage by Assets: MWZ's debt is not covered by short term assets (assets are 0.6x debt).
Financial Institutions Analysis
Asset Level: MWZ's level of assets compared to its equity is moderate.
Allowance for Bad Loans: Insufficient data to determine if MWZ has a sufficient allowance for bad loans.
Low Risk Liabilities: MWZ reports no customer deposits, loans are made up entirely of externally borrowed funds.
Loan Level: Insufficient data to determine if MWZ has an acceptable proportion of non-loan assets held.
Low Risk Deposits: MWZ has advanced significantly more loans than the customer deposits it holds.
Level of Bad Loans: Insufficient data to determine if MWZ has an appropriate level of bad loans.
Next Steps
Dividend
What is MetLife's current dividend yield, its reliability and sustainability?
3.81%
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: MWZ's dividend (3.81%) is higher than the bottom 25% of dividend payers in the German market (1.45%).
High Dividend: MWZ's dividend (3.81%) is low compared to the top 25% of dividend payers in the German market (3.78%).
Stable Dividend: MWZ's dividends per share have been stable in the past 10 years.
Growing Dividend: MWZ's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (27.8%), MWZ's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: MWZ's dividends in 3 years are forecast to be well covered by earnings (30.3% payout ratio).
Next Steps
Management
What is the CEO of MetLife's salary, the management and board of directors tenure and is there insider trading?
1.9yrs
Average management tenure
CEO
Michel Khalaf (55yo)
0.4yrs
Tenure
US$10,807,500
Compensation
Mr. Michel A. Khalaf has been President, Chief Executive Officer and Director of MetLife, Inc. since May 1, 2019. Mr. Khalaf served as President of U.S. Business & EMEA at MetLife, Inc. since July 11, 2017 ...
CEO Compensation Analysis
Compensation vs. Market: Michel has recently become CEO, making it difficult to compare their total compensation against companies of similar size in the German market.
Compensation vs Earnings: Michel's compensation has increased by more than 20% in the past year.
Management Age and Tenure
1.9yrs
Average Tenure
55yo
Average Age
Experienced Management: MWZ's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Age and Tenure
5.4yrs
Average Tenure
63.5yo
Average Age
Experienced Board: MWZ's board of directors are considered experienced (5.4 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 6,400 |
| Max Price | US$34.41 |
Ownership Breakdown
Management Team
David Lindstrom
Managing Director of Alternative Investments
- Tenure: 0yrs
Steve Goulart (60yo)
Executive VP & Chief Investment Officer
- Tenure: 8.4yrs
- Compensation: US$6.73m
Esther Lee (60yo)
Executive VP & Global Chief Marketing Officer
- Tenure: 4.8yrs
John Hall
Senior VP & Head of Investor Relations
- Tenure: 0yrs
Michel Khalaf (55yo)
CEO, President & Director
- Tenure: 0.4yrs
- Compensation: US$10.81m
Stephen Gauster (49yo)
Executive VP & General Counsel
- Tenure: 2.3yrs
John McCallion (45yo)
Executive VP
- Tenure: 1.4yrs
- Compensation: US$3.34m
Tammy Schock (47yo)
Executive VP & Chief Accounting Officer
- Tenure: 0.6yrs
Randy Clerihue
Chief Communications Officer
- Tenure: 1.5yrs
Susan Podlogar (55yo)
Executive VP & Chief HR Officer
- Tenure: 2.3yrs
Board Members
Bill Kennard (62yo)
Independent Director
- Tenure: 6.1yrs
- Compensation: US$331.68k
David Herzog (60yo)
Independent Director
- Tenure: 3yrs
- Compensation: US$341.68k
Carlos Gutierrez (65yo)
Independent Director
- Tenure: 6.6yrs
- Compensation: US$301.68k
Jim Kilts (71yo)
Independent Director
- Tenure: 14.8yrs
- Compensation: US$336.68k
Ned Kelly (65yo)
Independent Director
- Tenure: 4.7yrs
- Compensation: US$336.68k
Cathy Kinney (67yo)
Independent Director
- Tenure: 10.5yrs
- Compensation: US$306.68k
Michel Khalaf (55yo)
CEO, President & Director
- Tenure: 0.4yrs
- Compensation: US$10.81m
Robert Hubbard (60yo)
Non-Executive Chairman & Independent Lead Director
- Tenure: 0.5yrs
- Compensation: US$356.68k
Cheryl Grisé (66yo)
Independent Director
- Tenure: 15.7yrs
- Compensation: US$326.68k
Eric Sacha Clurfain (47yo)
Chairman
- Tenure: 0.7yrs
Company Information
MetLife, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: MetLife, Inc.
- Ticker: MWZ
- Exchange: DB
- Founded: 1868
- Industry: Life and Health Insurance
- Sector: Insurance
- Market Cap: US$43.255b
- Listing Market Cap: US$39.098b
- Shares outstanding: 936.45m
- Website: https://www.metlife.com
Number of Employees
Location
- MetLife, Inc.
- 200 Park Avenue
- New York
- New York
- 10166
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| MET | NYSE (New York Stock Exchange) | Yes | Common Stock | US | USD | Apr 2000 |
| MWZ | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Apr 2000 |
| MET * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Apr 2000 |
| 0K0X | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Apr 2000 |
| MET.PRA | NYSE (New York Stock Exchange) | PFD A FLT RATE | US | USD | Jun 2005 | |
| METB34 | BOVESPA (Bolsa de Valores de Sao Paulo) | EACH BDR REPR 1 COM STK USD0.01 | BR | BRL | Aug 2015 | |
| MET.PRE | NYSE (New York Stock Exchange) | 5.625 NCUM PFD E | US | USD | May 2018 |
Biography
MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/16 20:43 |
| End of Day Share Price | 2019/10/16 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.